Ascentage Pharma makes second attempt at IPO
China’s Ascentage Pharma Group International has refiled a prospectus for its second attempt to list on the Hong Kong Stock Exchange (HKEX).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: